The development of membrane technology for gas separation processes evolved with the fabrication of so-called mixed matrix membranes (MMMs) as an alternative to neat polymers, in order to improve the overall membrane effectiveness. Once the mixed matrix membranes are used, the gas separation properties of the porous materials used as fillers are combined with the economical processability and desirable mechanical properties of polymer matrix. Mixed mesoporous silica/polymer membranes with high CO
2
and O
2
permeability and selectivity were designed and prepared by incorporating MCM-41 particles into a polymer matrix. Ordered mesoporous silica MCM-41 with high surface confirmed by BET analysis were obtained and functionalized with amino groups. In order to obtain the mixed membranes, the mesoporous silica was embedded into the polysulfone matrix (PSF). Flat mixed matrix membranes with 5, 10, and 20 wt% MCM-41 and MCM-41-NH
2
loadings have been prepared via the polymer solution casting method. The phase's interactions were studied using scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transformed infrared spectroscopy (FTIR) and thermogravimetry (TGA), while the gas separation performances were evaluated using pure gases (CO
2
, O
2
, N
2
). The MCM-41/PSF and MCM-41-NH
2
/PSF membranes exhibited increased permeabilities for O
2
(between 1.2 and 1.7 Barrer) and CO
2
(between 4.2 and 8.1 Barrer) compared to the neat membrane (0.8 Barrer). The loss of selectivity for the O
2
/N
2
(between 6 and 8%) and CO
2
/N
2
(between 25 and 41%) gas pairs was not significant compared with the pure membrane (8 and 39%, respectively). The MCM-41/PSF membranes were more selective for CO
2
/N
2
than the O
2
/N
2
pair, due to the size difference between CO
2
and N
2
molecules and to the condensability of CO
2
, leading to an increase of solubility. Stronger interactions have been noticed for MCM-41-NH
2
/PSF membranes due to the amino groups, with the selectivity increasing for both gas pairs compared with the MCM-41/PSF membranes.
The recovery of osmium from residual osmium tetroxide (OsO4) is a necessity imposed by its high toxicity, but also by the technical-economic value of metallic osmium. An elegant and extremely useful method is the recovery of osmium as a membrane catalytic material, in the form of nanoparticles obtained on a polymeric support. The subject of the present study is the realization of a composite membrane in which the polymeric matrix is the polypropylene hollow fiber, and the active component consists of the osmium nanoparticles obtained by reducing an alcoholic solution of osmium tetroxides directly on the polymeric support. The method of reducing osmium tetroxide on the polymeric support is based on the use of 10-undecenoic acid (10–undecylenic acid) (UDA) as a reducing agent. The osmium tetroxide was solubilized in t–butanol and the reducing agent, 10–undecenoic acid (UDA), in i–propanol, t–butanol or n–decanol solution. The membranes containing osmium nanoparticles (Os–NP) were characterized morphologically by the following: scanning electron microscopy (SEM), high-resolution SEM (HR–SEM), structurally: energy-dispersive spectroscopy analysis (EDAX), Fourier transform infrared (FTIR) spectroscopy. In terms of process performance, thermal gravimetric analysis was performed by differential scanning calorimetry (TGA, DSC) and in a redox reaction of an organic marker, p–nitrophenol (PNP) to p–aminophenol (PAP). The catalytic reduction reaction with sodium tetraborate solution of PNP to PAP yielded a constant catalytic rate between 2.04 × 10−4 mmol s–1 and 8.05 × 10−4 mmol s−1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.